Tuberculosis after conversion from azathioprine to mycophenolate mofetil in a long-term renal transplant recipient

被引：17
|
作者：
Mercadal, L [1 ]
Foltz, V [1 ]
Isnard-Bagnis, C [1 ]
Ourahma, S [1 ]
Deray, G [1 ]
机构：
[1] Hop La Pitie Salpetriere, Dept Nephrol, F-75013 Paris, France
来源：
TRANSPLANTATION PROCEEDINGS | 2005年 / 37卷 / 10期
关键词：
D O I：
10.1016/j.transproceed.2005.11.010
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We report the third case in the literature of a patient with a long-lasting renal allograft who experienced tuberculosis just after the switch from azathioprine to mycophenolate mofetil. The switch was likely responsible for the reactivation of dormant tuberculosis; prophylactic antituberculous treatment should be considered in cases of such a therapeutic change.
引用
收藏
页码：4241 / 4243
页数：3
相关论文
共 50 条
  • [1] Conversion from azathioprine to Mycophenolate Mofetil in pediatric renal transplant recipients
    Charbit, M
    Guest, G
    Gagnadoux, MF
    Niaudet, P
    Broyer, M
    TRANSPLANTATION, 1999, 67 (07) : S184 - S184
  • [2] Reactivation of tuberculosis after conversion from azathioprine to mycophenolate mofetil 16 years after renal transplantation
    Waiser, J
    Schötschel, R
    Budde, K
    Neumayer, HH
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (03)
  • [3] Cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion
    Thervet, E
    Morelon, E
    Ducloux, D
    Bererhi, L
    Noël, LH
    Bedrossian, JJ
    Puget, S
    Chalopin, JM
    Mihatsch, M
    Legendre, C
    Kreis, H
    CLINICAL TRANSPLANTATION, 2000, 14 (06) : 561 - 566
  • [4] Long-Term Mycophenolate Mofetil Treatment in Pediatric Renal Transplant Patients
    Roberts, John P.
    Potter, Donald
    Bouw, M. Rene
    DIALYSIS & TRANSPLANTATION, 2009, 38 (11) : 445 - +
  • [5] A pilot study of cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion
    Thervet, E
    Morelon, E
    Ducloux, D
    Bererhi, L
    Noël, LH
    Janin, A
    Bedrossian, J
    Puget, S
    Chalopin, JM
    Mihatsch, M
    Legendre, C
    Kreis, H
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (08) : 2778 - 2778
  • [6] Long-term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation
    Creput, Caroline
    Blandin, Frederique
    Deroure, Benjamin
    Roche, Bruno
    Saliba, Faouzi
    Charpentier, Bernard
    Samuel, Didier
    Durrbach, Antoine
    LIVER TRANSPLANTATION, 2007, 13 (07) : 1004 - 1010
  • [7] Haemolytic-uraemic syndrome in a renal transplant recipient treated by conversion to mycophenolate mofetil
    McGregor, DO
    Robson, RA
    Lynn, KL
    NEPHRON, 1998, 80 (03) : 365 - 366
  • [8] Long-term benefit of mycophenolate mofetil in renal transplantation
    Lang, P
    Pardon, A
    Audard, V
    TRANSPLANTATION, 2005, 79 (03) : S47 - S48
  • [9] Long-term effects of the conversion from azathioprine (AZA) to mycophenolate mofetil (MMF) in patients with chronic allograft dysfunction (CAD).
    Alves, EC
    Felipe, CR
    Park, SI
    Silva, LA
    Machado, PG
    Garcia, R
    Tedesco-Silva, H
    Medina-Pestana, JO
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 220 - 220
  • [10] Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil
    Hardinger, KL
    Brennan, DC
    Lowell, J
    Schnitzler, MA
    TRANSPLANT INTERNATIONAL, 2004, 17 (10) : 609 - 616
12345